| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | K08BK043YS |
| InChI Key | XILNRORTJVDYRH-HKUYNNGSSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H23F3N6O |
| Molecular Weight | 432.45 |
| AlogP | 3.27 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 76.89 |
| Molecular species | BASE |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 31.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Neurokinin 1 receptor antagonist | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Neurokinin receptor
|
- | 0 | - | 0 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Stress Disorders, Post-Traumatic | 2 | D013313 | ClinicalTrials |
| Sleep Initiation and Maintenance Disorders | 2 | D007319 | ClinicalTrials |
| Bipolar Disorder | 1 | D001714 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL522302 |
| DrugBank | DB12436 |
| FDA SRS | K08BK043YS |
| Guide to Pharmacology | 5752 |
| SureChEMBL | SCHEMBL310338 |